Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Calais

Showing results (21-30 of 563) with videos related to

Pageof 57
Sort By:
Clinical Nuclear Medicine|July 13, 2012
Outpatient 131I-rituximab radioimmunotherapy for non-Hodgkin lymphoma: a study in safetyPhillipe J Calais, John Harvey Turner
World Journal of Nuclear Medicine|February 2, 2013
Standard Operating Procedure for Prospective Individualised Dosimetry for ([131])I-rituximab Radioimmunotherapy of Non-Hodgkin's LymphomaPhillipe J Calais, J Harvey Turner
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 29, 1999
[Chemoradiotherapy of carcinomas of the upper aerodigestive tract]J Bourhis, G Calais, F Eschwège
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Adenocarcinomas of the distal esophagus and cardia. Anatomy and volume of irradiation]G Calais, E Asquier, P Louisot
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2001
[Gross tumor volume and clinical target volume: esophageal tumors]G Calais, E Asquier, P Louisot
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 10, 2014
[Evaluation of the therapeutic response after stereotactic body radiation therapy for liver tumors]G Janoray, I Barillot, G Calais
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|April 13, 2001
A 3-D marker-free system for the analysis of movement disabilities--an application to the legsF Marzani, E Calais, L Legrand
Annals of Nuclear Medicine|April 2, 2014
Radiation safety of outpatient 177Lu-octreotate radiopeptide therapy of neuroendocrine tumorsPhillipe J Calais, J Harvey Turner
Urology|May 12, 2009
Efficacy of bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokinesPaula A Videira, Fernando M Calais, Manuela Correia, et al.
Targeted Oncology|May 26, 2025
PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand TherapyPhillip H Kuo, Jeremie Calais, Mike Crosby
Pageof 57

Showing results (21-30 of 563) with videos related to

Sort By:
Pageof 57
Clinical Nuclear Medicine|July 13, 2012
Outpatient 131I-rituximab radioimmunotherapy for non-Hodgkin lymphoma: a study in safetyPhillipe J Calais, John Harvey Turner
World Journal of Nuclear Medicine|February 2, 2013
Standard Operating Procedure for Prospective Individualised Dosimetry for ([131])I-rituximab Radioimmunotherapy of Non-Hodgkin's LymphomaPhillipe J Calais, J Harvey Turner
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 29, 1999
[Chemoradiotherapy of carcinomas of the upper aerodigestive tract]J Bourhis, G Calais, F Eschwège
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|January 19, 2002
[Adenocarcinomas of the distal esophagus and cardia. Anatomy and volume of irradiation]G Calais, E Asquier, P Louisot
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 22, 2001
[Gross tumor volume and clinical target volume: esophageal tumors]G Calais, E Asquier, P Louisot
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|May 10, 2014
[Evaluation of the therapeutic response after stereotactic body radiation therapy for liver tumors]G Janoray, I Barillot, G Calais
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|April 13, 2001
A 3-D marker-free system for the analysis of movement disabilities--an application to the legsF Marzani, E Calais, L Legrand
Annals of Nuclear Medicine|April 2, 2014
Radiation safety of outpatient 177Lu-octreotate radiopeptide therapy of neuroendocrine tumorsPhillipe J Calais, J Harvey Turner
Urology|May 12, 2009
Efficacy of bacille Calmette-Guérin immunotherapy predicted by expression of antigen-presenting molecules and chemokinesPaula A Videira, Fernando M Calais, Manuela Correia, et al.
Targeted Oncology|May 26, 2025
PSMA PET Imaging in the Management of Patients with Metastatic Castration-Resistant Prostate Cancer Treated with Radioligand TherapyPhillip H Kuo, Jeremie Calais, Mike Crosby
Pageof 57